← Back to Clinical Trials
Recruiting NCT01617408

NCT01617408 Brain Stimulation and Vision Testing

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01617408
Status Recruiting
Phase
Sponsor National Institute of Mental Health (NIMH)
Condition fMRI
Study Type OBSERVATIONAL
Enrollment 665 participants
Start Date 2013-03-04
Primary Completion

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 50 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 665 participants in total. It began in 2013-03-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: -The brain has two systems for recognizing objects. One system recognizes what an object is, and the other system recognizes where the object is located. However, there is much about how the brain handles and interprets the information from these two systems that is still unclear. Researchers want to study the parts of the brain that are involved in how vision is processed. They will use magnetic resonance imaging (MRI) and transcranial magnetic stimulation (TMS) or transcranial electrical stimulation (tES) on the brain. MRI measures what parts of the brain become more active when tasks are performed. TMS uses magnetic pulses to temporarily change the activity in parts of the brain. tES uses electrical current to temporarily change brain function. Objectives: -To better understand how people visually recognize different types of objects. Eligibility: -Healthy volunteers between 18 and 50 years of age, who only speak English. Design: * This study includes many different experiments on vision. Each experiment may combine visual tasks, MRI scans, and TMS or tES. Participants may be asked to have several different tests. Each test will require a separate visit to the National Institutes of Health. * Participants will be screened with a physical exam and medical history. They will have a baseline brain scan at the first visit. * Participants may do visual tasks alone, with MRI only, with TMS or tES only, or with MRI and TMS or tES combined. For the visual tasks, they will look at pictures of objects on a computer screen. Sometimes the images will appear very briefly (less than one-tenth of a second). Sometimes they will appear for up to 5 seconds. These images will be of things like faces, bodies, tools, and scenes. Participants will be asked to respond in different ways to the pictures. They may respond by typing on a computer keyboard or by pressing a button. Participants will have time to practice the tasks before the experiment. * Participants will remain on the study for up to 3 years.

Eligibility Criteria

* INCLUSION CRITERIA: Healthy Ages 18-50 years (inclusive) Able to read and write in English to guarantee understanding of all written and spoken instructions, which are in English EXCLUSION CRITERIA: Individuals with conditions that could pose a risk relating to the safety of the MRI procedure, the TMS procedure or the combined TBS and fMRI procedure will be excluded from the protocol such as: * Those with ferromagnetic metal in the cranial cavity or eye, e.g. aneurysm clip, implanted neural stimulator, cochlear implant, ocular foreign body. * Those with an abnormality on a structural MRI. * Those with an implanted cardiac pacemaker or auto-defibrillator * Those with an insulin pump. * Those with an irremovable body piercing * Pregnant women * Those with a visual impairment that will prevent them from performing the task * Those without consent capacity will not be enrolled * Those who do not understand the study instructions * Those with a history of neurological problems. Neurological problems include, but are not limited to; family history of epilepsy, history of seizures and recurrent migraines. * Those using medicines that can lower the seizure threshold. These can include but are not limited to; imipramine, amitriptyline, doxepine, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines. * Those with a visual impairment that will prevent them from performing the task * Those who have a significant psychiatric illness or have a history of psychiatric illness. * NIMH staff/employees/family members

Contact & Investigator

Central Contact

NIMH LBC Volunteer

✉ nimhlbcvolunteer@mail.nih.gov

📞 (301) 827-5157

Principal Investigator

Christopher I Baker, Ph.D.

PRINCIPAL INVESTIGATOR

National Institute of Mental Health (NIMH)

Frequently Asked Questions

Who can join the NCT01617408 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying fMRI. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT01617408 currently recruiting?

Yes, NCT01617408 is actively recruiting participants. Contact the research team at nimhlbcvolunteer@mail.nih.gov for enrollment information.

Where is the NCT01617408 trial being conducted?

This trial is being conducted at Bethesda, United States.

Who is sponsoring the NCT01617408 clinical trial?

NCT01617408 is sponsored by National Institute of Mental Health (NIMH). The principal investigator is Christopher I Baker, Ph.D. at National Institute of Mental Health (NIMH). The trial plans to enroll 665 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology